share_log

Cantor Fitzgerald Reiterates Overweight on Agios Pharmaceuticalsto Overweight

Cantor Fitzgerald Reiterates Overweight on Agios Pharmaceuticalsto Overweight

Cantor Fitzgerald重申對Agios Pharmaceutical的「增持」評級
Benzinga ·  12/18 21:57

Cantor Fitzgerald analyst Eric Schmidt reiterates Agios Pharmaceuticals (NASDAQ:AGIO) from Overweight to Overweight.

坎託·菲茨傑拉德分析師埃裏克·施密特重申Agios Pharmicals(納斯達克股票代碼:AGIO)從 「增持」 改爲 「增持」。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論